Abstract
It is shown that the nonglycoside cardiotonic drug suphan exhibits antiarrhythmic and antifibrillatory activity, although less pronounced than that of lidocaine. When lidocaine was administered after suphan, the antifibrillatory effects of both preparations increased.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. L. Belen'kii,Quantitative Evaluation of Pharmacological Effect [in Russian], Leningrad (1963).
E. I. Gendenshtein, V. P. Balashov, Ya. V. Kostin,et al., Farmakol. Toksikol.,53, No. 1, 30–32 (1990).
E. I. Gendenshtein, Ya. V. Kostin, N. N. Markelova,et al., —Ibid., No. 4, pp. 28–30.
A. I. Grinevich, I. S. Chekman, P. A. Galenko-Yaroshevskii,et al., Dokl. Akad. Nauk Ukraine, No. 5, 169–173 (1994).
P. F. Litvitskii, V. A. Sandrikov, and E. A. Demurov,Adaptive and Pathogenic Effects of Reperfusion and Reoxygenation of the Myocardium [in Russian], Moscow (1994).
V. B. Prozorovskii,Farmakol. Toksikol.,25, No. 1, 115–119. (1962).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 123, No. 5, pp. 545–547, May, 1997
Rights and permissions
About this article
Cite this article
Galenko-Yaroshevskii, P.A., Uvarov, A.V., Galygo, D.S. et al. Effect of suphan, lidocaine, and their combination on early occlusion and reperfusion arrhythmias in cats. Bull Exp Biol Med 123, 474–476 (1997). https://doi.org/10.1007/BF02445323
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02445323